Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700016406

Trial Profile

Clinical Trials Insight: 700016406

Phase of Trial: Phase II

Latest Information Update: 19 Oct 2009

At a glance

  • Drugs TRU 015 (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Sponsors Emergent BioSolutions
  • Most Recent Events

    • 19 Oct 2009 Results from the open-label re-treatment phase of the study reported in a Trubion Pharmaceuticals media release.
    • 18 May 2009 Results from the re-treatment portion will be presented at the 2009 European League Against Rheumatism (EULAR) conference on June 11, reported by Trubion Pharmaceuticals.
    • 11 Sep 2007 Preliminary results have been reported.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top